ESSA Pharma Inc.

EPIX · NASDAQ
Analyze with AI
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Assets
Cash & Equivalents$103,710$33,702$57,076$137,825
Short-Term Investments$23,051$114,374$0$57,102
Receivables$163$135$6$489
Inventory$0$0$110,607$0
Other Curr. Assets$636$585$1,816$2,182
Total Curr. Assets$127,560$148,797$169,505$197,598
Property Plant & Equip (Net)$295$68$186$308
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$257$257$259$259
Total NC Assets$552$325$446$568
Other Assets$0$0-$446$0
Total Assets$128,112$149,122$169,505$198,166
Liabilities
Payables$2,404$2,028$955$1,426
Short-Term Debt$248$80$134$121
Tax Payable$0$0-$35,162-$36,840
Deferred Revenue$0$0$0$0
Other Curr. Liab.$649$1,386$36,384$39,223
Total Curr. Liab.$3,301$3,495$2,310$3,930
LT Debt$205$0$76$210
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$20
Total NC Liab.$205$0$77$231
Other Liabilities$0$0$0$0
Cap. Leases$329$80$210$331
Total Liabilities$3,506$3,495$2,387$4,160
Equity
Pref Stock$0$0$0$0
Common Stock$279,862$278,162$278,089$277,415
Retained Earnings-$208,004-$179,461-$152,879-$117,776
AOCI-$2,063-$2,120-$2,135-$2,076
Other Equity$54,811$49,047$44,044$36,443
Total Equity$124,606$145,627$167,118$194,006
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$128,112$149,122$169,505$198,166
Net Debt-$103,256-$33,622-$56,866-$137,494